phII Study of an HDAC Inhibitor in Very High-risk Relapsed/Refractory Hodgkin's Lymphoma Patients
Clinical trial NCT00496431 · TERMINATED
Trial details
- NCT number
- NCT00496431
- Sponsor
- Italfarmaco
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2009-03-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.